Orchid Pharma Ltd
NSE:ORCHPHARMA

Watchlist Manager
Orchid Pharma Ltd Logo
Orchid Pharma Ltd
NSE:ORCHPHARMA
Watchlist
Price: 1 797.4 INR 4.1%
Market Cap: 91.2B INR
Have any thoughts about
Orchid Pharma Ltd?
Write Note

Intrinsic Value

The intrinsic value of one ORCHPHARMA stock under the Base Case scenario is 1 260.63 INR. Compared to the current market price of 1 797.4 INR, Orchid Pharma Ltd is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ORCHPHARMA Intrinsic Value
1 260.63 INR
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Orchid Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ORCHPHARMA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ORCHPHARMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ORCHPHARMA?
Bearish
Neutral
Bullish

Fundamental Analysis

1 797.4 INR
+4.1%
+4.1%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Orchid Pharma Ltd
IN
Pharmaceuticals
Market Cap
91.2B INR
IPO
Sep 6, 1993
Employees
-
India
Market Cap
91.2B INR
Industry
Pharmaceuticals
IPO
Sep 6, 1993
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Orchid Pharma Ltd

Provide an overview of the primary business activities
of Orchid Pharma Ltd.

What unique competitive advantages
does Orchid Pharma Ltd hold over its rivals?

What risks and challenges
does Orchid Pharma Ltd face in the near future?

Has there been any significant insider trading activity
in Orchid Pharma Ltd recently?

Summarize the latest earnings call
of Orchid Pharma Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Orchid Pharma Ltd.

Provide P/S
for Orchid Pharma Ltd.

Provide P/E
for Orchid Pharma Ltd.

Provide P/OCF
for Orchid Pharma Ltd.

Provide P/FCFE
for Orchid Pharma Ltd.

Provide P/B
for Orchid Pharma Ltd.

Provide EV/S
for Orchid Pharma Ltd.

Provide EV/GP
for Orchid Pharma Ltd.

Provide EV/EBITDA
for Orchid Pharma Ltd.

Provide EV/EBIT
for Orchid Pharma Ltd.

Provide EV/OCF
for Orchid Pharma Ltd.

Provide EV/FCFF
for Orchid Pharma Ltd.

Provide EV/IC
for Orchid Pharma Ltd.

Show me price targets
for Orchid Pharma Ltd made by professional analysts.

What are the Revenue projections
for Orchid Pharma Ltd?

How accurate were the past Revenue estimates
for Orchid Pharma Ltd?

What are the Net Income projections
for Orchid Pharma Ltd?

How accurate were the past Net Income estimates
for Orchid Pharma Ltd?

What are the EPS projections
for Orchid Pharma Ltd?

How accurate were the past EPS estimates
for Orchid Pharma Ltd?

What are the EBIT projections
for Orchid Pharma Ltd?

How accurate were the past EBIT estimates
for Orchid Pharma Ltd?

Compare the revenue forecasts
for Orchid Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Orchid Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Orchid Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Orchid Pharma Ltd compared to its peers.

Compare the P/E ratios
of Orchid Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Orchid Pharma Ltd with its peers.

Analyze the financial leverage
of Orchid Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Orchid Pharma Ltd.

Provide ROE
for Orchid Pharma Ltd.

Provide ROA
for Orchid Pharma Ltd.

Provide ROIC
for Orchid Pharma Ltd.

Provide ROCE
for Orchid Pharma Ltd.

Provide Gross Margin
for Orchid Pharma Ltd.

Provide Operating Margin
for Orchid Pharma Ltd.

Provide Net Margin
for Orchid Pharma Ltd.

Provide FCF Margin
for Orchid Pharma Ltd.

Show all solvency ratios
for Orchid Pharma Ltd.

Provide D/E Ratio
for Orchid Pharma Ltd.

Provide D/A Ratio
for Orchid Pharma Ltd.

Provide Interest Coverage Ratio
for Orchid Pharma Ltd.

Provide Altman Z-Score Ratio
for Orchid Pharma Ltd.

Provide Quick Ratio
for Orchid Pharma Ltd.

Provide Current Ratio
for Orchid Pharma Ltd.

Provide Cash Ratio
for Orchid Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Orchid Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Orchid Pharma Ltd?

What is the current Free Cash Flow
of Orchid Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Orchid Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Orchid Pharma Ltd

Current Assets 8.3B
Cash & Short-Term Investments 2.5B
Receivables 2.2B
Other Current Assets 3.7B
Non-Current Assets 8B
Long-Term Investments 525.1m
PP&E 6.6B
Intangibles 185.9m
Other Non-Current Assets 745.3m
Current Liabilities 2.8B
Accounts Payable 2.2B
Other Current Liabilities 572.8m
Non-Current Liabilities 1.3B
Long-Term Debt 1.3B
Other Non-Current Liabilities 36.6m
Efficiency

Earnings Waterfall
Orchid Pharma Ltd

Revenue
9B INR
Cost of Revenue
-5.3B INR
Gross Profit
3.7B INR
Operating Expenses
-2.8B INR
Operating Income
932.9m INR
Other Expenses
262.6m INR
Net Income
1.2B INR

Free Cash Flow Analysis
Orchid Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ORCHPHARMA Profitability Score
Profitability Due Diligence

Orchid Pharma Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
55/100
Profitability
Score

Orchid Pharma Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

ORCHPHARMA Solvency Score
Solvency Due Diligence

Orchid Pharma Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
82/100
Solvency
Score

Orchid Pharma Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORCHPHARMA Price Targets Summary
Orchid Pharma Ltd

Wall Street analysts forecast ORCHPHARMA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORCHPHARMA is 1 638.12 INR with a low forecast of 1 297.85 INR and a high forecast of 1 914.15 INR.

Lowest
Price Target
1 297.85 INR
28% Downside
Average
Price Target
1 638.12 INR
9% Downside
Highest
Price Target
1 914.15 INR
6% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ORCHPHARMA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ORCHPHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ORCHPHARMA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one ORCHPHARMA stock?

The intrinsic value of one ORCHPHARMA stock under the Base Case scenario is 1 260.63 INR.

Is ORCHPHARMA stock undervalued or overvalued?

Compared to the current market price of 1 797.4 INR, Orchid Pharma Ltd is Overvalued by 30%.

Back to Top